Louisville group joins nationwide call for constitutional reform to campaign finance
01/19/2013 02:24 PM
George Schuhmann, a retired lawyer from Louisville, first got involved in politics two years ago when he was inspired to get money _out of politics.
Schuhmann organized a rally Saturday — one of more than 100 across the country — aimed at highlighting the need for campaign finance reforms.
The roughtly two-dozen protesters who joined Schuhmann in downtown Louisville support amending the U.S. Constitution to bar corporate donations in the U.S. political process and to undo the precedent set by the Supreme Court in the Citizens United case. But the group isn’t expecting this to happen overnight.
“It’s a wonderfully complicated jurisprudential undertaking to do that job,” Schuhmann told Pure Politics. “So it’s going to take some time to get the wording right.”
One of the speakers at the small rally, state Rep. Mary Lou Marzian, D-Louisville, has filed House Concurrent Resolution 6 in which the General Assembly would call on Congress to propose a 28th Amendment to the Constitition.
Schuhmann said the goal is to lobby lawmakers to pass that resolution, if not in 2013, during the 2014 session.
And the effort could need money to fight money. Schuhmann said he hopes the group he has formed, calling itself Citizens Voices, can put together a Political Action Committee to raise about $25,000 to help fund lobbying efforts.
Here are some highlights of some the remarks from Marzian and Richard Beliles, the Louisville attorney and chairman of Common Cause Kentucky:
Below the Fold
Louisville Democratic consultant tied to Longmeyer, MC Squared kickback scheme pleads guilty to bribery charges
Northern Kentucky legislator hopes to make impact by serving on national mental health and substance abuse task force
Chief Justice Minton says judges need higher wages, will present judicial redistricting plan next legislative session
Rand Paul makes Senate campaign stops in northern Kentucky; promises hearing in Kentucky on high cost of EpiPen
Subscribe and get the latest political intelligence delivered to your inbox.